BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11213791)

  • 1. Preformulation experiences and in vitro model studies with spironolactone-containing suppositories.
    Regdon G; Deák D; Regdon G; Muskó Z; Erös I
    Pharmazie; 2001 Jan; 56(1):70-3. PubMed ID: 11213791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Formulation and analysis of suppositories containing papaverine hydrochloride. Part 2. In vitro membrane diffusion studies].
    Regdon G; Vastag T; Regdon G; Selmeczi B
    Acta Pharm Hung; 1991 Nov; 61(6):303-9. PubMed ID: 1785359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biopharmaceutical investigation of rectal suppositories. Part 2(1): Pharmaceutical and biological availability of phenobarbital and phenobarbital-sodium.
    Minkov E; Lambov N; Kirchev D; Bantutova I; Tencheva J
    Pharmazie; 1985 Apr; 40(4):257-9. PubMed ID: 3839310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biopharmaceutical study of aminophenazone-containing suppositories. 1. Experimental materials and methods, determination of physical qualities of the suppositories].
    Tantó M; Ecsy Z; Selmeczi B; Regdon G
    Acta Pharm Hung; 1990 Jul; 60(4):143-8. PubMed ID: 2239341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The solubility of drugs in molten suppository bases].
    Pflegel P; Schöbel H; Klaus T; Raguse U
    Pharmazie; 1990 Apr; 45(4):266-7. PubMed ID: 2381978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Formulation and in vitro investigation of antibacterial vaginal suppositories. Part 2. In vitro membrane diffusion and microbiologic studies].
    Tariné Gombkŏtö Z; Molnár J; Farkasné Gunics G; Regdon G; Selmeczi B
    Acta Pharm Hung; 1992 Nov; 62(6):302-9. PubMed ID: 1488916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preparation and in vitro study of suppositories containing No-Spa. II. Determination of release of the active principle by membrane diffusion methods].
    Regdon G; Kovács B; Pécsiné Szebellédi I; Regdon G
    Acta Pharm Hung; 1989 Jan; 59(1):32-41. PubMed ID: 2711839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biopharmaceutical study of aminophenazone-containing suppositories. 2. Results of in vitro drug release and in vivo drug absorption].
    Tantó M; Ecsy Z; Selmeczi B; Regdon G
    Acta Pharm Hung; 1990 Jul; 60(4):149-55. PubMed ID: 2239342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acetylsalicylic acid containing suppositories with lipophilik bases. 1. Manufacture by the molding process and investigation of physical parameters].
    Regdon E; Regdon G; Karolyi K
    Pharmazie; 1976; 31(2):114-6. PubMed ID: 959252
    [No Abstract]   [Full Text] [Related]  

  • 10. Preformulation studies on ingredients of suppository bases [proceedings].
    Liversidge GG; Grant DJ; Padfield JM
    J Pharm Pharmacol; 1979 Dec; 31 Suppl():53P. PubMed ID: 42729
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on aminophenazone and phenobarbital release from suppositories prepared on different bases.
    Piasecka H; Zakrzewski Z
    Pol J Pharmacol Pharm; 1976; 28(2):199-203. PubMed ID: 934948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro release of chloramphenicol from different suppository bases.
    Kassem AA; Nour El-Din E; Abd El-Bary A; Fadel HM
    Pharmazie; 1975 Jul; 30(7):472-5. PubMed ID: 1178767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A study of pyramidone suppositories].
    Mihalache M; Perţea M; Verbuţă A
    Rev Med Chir Soc Med Nat Iasi; 1990; 94(2):389-92. PubMed ID: 2100858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preformulation studies on suppositories by thermal methods.
    Giordano F; La Manna A; Bettinetti GP; Zamparutti M
    Boll Chim Farm; 1990 Apr; 129(4):160-5. PubMed ID: 2245004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Formulation and in vitro investigation of antibacterial vaginal suppositories. Part 1. Considerations in selecting the vehicle. Methods and results of the physical examination].
    Tariné Gombkötö Z; Regdon G; Regdon G; Selmeczi B
    Acta Pharm Hung; 1992 Nov; 62(6):295-301. PubMed ID: 1488915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of progesterone suppositories.
    Roffe BD; Zimmer RA; Derewicz HJ
    Am J Hosp Pharm; 1977 Dec; 34(12):1344-6. PubMed ID: 596385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acetylsalicylic acid suppositories with a lipophilic base. 2. Chemical stability of the active ingredient].
    Karolyi I; Kedvessy G; Regdon G; Regdon E
    Pharmazie; 1976; 31(3):179-80. PubMed ID: 959272
    [No Abstract]   [Full Text] [Related]  

  • 18. Suppositories formulation and drug release.
    Moes AJ
    Boll Chim Farm; 1989 Jan; 128(1):5-12. PubMed ID: 2673303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro method for measuring the release of antibiotics from suppository bases.
    Yousef RT; Ghobashy AA
    Dan Tidsskr Farm; 1969; 43(2):31-8. PubMed ID: 5793364
    [No Abstract]   [Full Text] [Related]  

  • 20. [Influence of excipients and storage conditions on drug preservation. IV. Suppositories with acetyl salicylic acid base].
    Delonca H; Puech A; Segura G; Joachim J
    J Pharm Belg; 1972; 27(1):50-6. PubMed ID: 5017455
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.